Clinton Group
1
30M
1
0.03
1
- Areas of investment
Summary
Clinton Group appeared to be the VC, which was created in 1991. The leading representative office of defined VC is situated in the New York. The venture was found in North America in United States.
The usual cause for the fund is to invest in rounds with 5 partakers. Despite the Clinton Group, startups are often financed by Mitsui Global Investment, Toyota Motor Corporation, Touradji Capital Management. The meaningful sponsors for the fund in investment in the same round are Sofinnova Partners, NAXOS Capital Partners, Mitsui & Co. In the next rounds fund is usually obtained by Hercules Capital, Inc., Export Development Canada, Comerica Incorporated.
Besides them, we counted 3 critical employees of this fund in our database.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most successful fund investment fields, there are Chemical, Biotechnology. Among the most popular portfolio startups of the fund, we may highlight BioAmber.
Deals in the range of 10 - 50 millions dollars are the general things for fund. The higher amount of exits for fund were in 2013. The top activity for fund was in 2012. The fund is generally included in less than 2 deals every year.
Investments analytics
Analytics
- Total investments
- 1
- Lead investments
- 0
- Exits
- 1
- Rounds per year
- 0.03
- Investments by industry
- Biotechnology (1)
- Chemical (1)
- GreenTech (1)
- Investments by region
-
- United States (1)
- Peak activity year
- 2012
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 13
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| BioAmber | 22 Feb 2012 | Biotechnology, Chemical, GreenTech | Late Stage Venture | 30M | United States, Minnesota |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.